No, the MRIdian linac technology only improves our solution and is being developed to be an upgrade to existing MRIdian systems. ViewRay has applied the same double-focused multi-leaf collimator technology, originally designed to improve Cobalt-60 systems, to ViewRay’s MRIdian linac technology. We believe incorporating this beam shaping technology with the already sharp linac radiation source results in the sharpest linac beam to be developed in the industry.
MRIdian with linac radiation is available for sale and delivery in the USA and EU. It is also approved in Canada, Japan, Korea, Taiwan, United Arab Emirates, and Turkey.MRIdian with cobalt radiation is available for sale and delivery in: USA, EU, Japan, China, Taiwan, United Arab Emirates, and Korea.
ViewRay started operations as a Florida corporation in 2004 and subsequently reincorporated in Delaware in 2007. With this merger the company will continue to be incorporated in Delaware.
ViewRay is traded on the Nasdaq under the symbol "VRAY”.
American Stock Transfer is ViewRay’s transfer agent. Investors interested in purchasing shares directly or registered shareholders wanting to make changes to their account should contact American Stock Transfer. If you own shares through a brokerage firm, you need to contact the brokerage firm directly to make any account changes.American Stock Transfer & Trust Company, LLC6201 15th AvenueBrooklyn, NY 11219(800) 937-5449Website: www.amstock.comEmail: info@amstock.com
ViewRay’s fiscal year runs from January 1 through December 31.
To review our corporate governance guidelines and related information, please go to the Corporate Governance section of our IR website.
You can reach ViewRay’s Investor Relations team via e-mail at investors@viewray.com or 1.844.MRIDIAN (674-3426).
The company’s principal executive offices are at 2 Thermo Fisher Way, Oakwood Village, Ohio 44146. We also have offices in Silicon Valley, California at 815 E. Middlefield, Rd., Mountain View, CA 94043.